000 | 01792 a2200529 4500 | ||
---|---|---|---|
005 | 20250516150250.0 | ||
264 | 0 | _c20140123 | |
008 | 201401s 0 0 eng d | ||
022 | _a1476-5594 | ||
024 | 7 |
_a10.1038/onc.2013.156 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKi, M K | |
245 | 0 | 0 |
_aHuman antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro. _h[electronic resource] |
260 |
_bOncogene _cNov 2013 |
||
300 |
_a5449-57 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aBiomarkers, Tumor _xchemistry |
650 | 0 | 4 |
_aCell Adhesion Molecules _xantagonists & inhibitors |
650 | 0 | 4 | _aCell Communication |
650 | 0 | 4 | _aCell Movement |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xcytology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xchemistry |
650 | 0 | 4 |
_aLectins, C-Type _xantagonists & inhibitors |
650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xmetabolism |
650 | 0 | 4 | _aProtein Structure, Tertiary |
650 | 0 | 4 |
_aPseudopodia _xmetabolism |
650 | 0 | 4 |
_aSingle-Chain Antibodies _xchemistry |
700 | 1 | _aJeoung, M H | |
700 | 1 | _aChoi, J R | |
700 | 1 | _aRho, S-S | |
700 | 1 | _aKwon, Y-G | |
700 | 1 | _aShim, H | |
700 | 1 | _aChung, J | |
700 | 1 | _aHong, H J | |
700 | 1 | _aSong, B D | |
700 | 1 | _aLee, S | |
773 | 0 |
_tOncogene _gvol. 32 _gno. 48 _gp. 5449-57 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2013.156 _zAvailable from publisher's website |
999 |
_c22724860 _d22724860 |